The chemical class of Mel-18 activators encompasses a diverse array of compounds that have the ability to activate or modulate the activity of Mel-18, a critical member of the Polycomb group proteins involved in epigenetic regulation. These activators primarily target key players in the intricate landscape of histone methylation and demethylation, indirectly influencing Mel-18 activity. Notably, compounds like BIX-01294, UNC0638, A-366, UNC0642, UNC926, UNC0646, UNC2399, Chaetocin, DZNep, GSK126, EPZ-6438, and others act as activators or modulators of histone methyltransferases, specifically targeting G9a, SUV39H1, and EZH2. The specific biochemical pathways influenced by these activators involve the regulation of histone methylation patterns, a crucial aspect of epigenetic control orchestrated by Polycomb group proteins, including Mel-18. For instance, BIX-01294 and UNC0638, by inhibiting G9a, and Chaetocin, by inhibiting SUV39H1, modulate histone methylation dynamics, affecting the function of Mel-18. Similarly, compounds like GSK126 and EPZ-6438, as EZH2 inhibitors, provide insights into the intricate interplay between histone modifications and Mel-18-mediated cellular responses.
Understanding the implications of Mel-18 activation requires a nuanced exploration of the epigenetic landscape, unraveling the consequences of altered histone methylation patterns on cellular responses. The chemical class of Mel-18 activators stands at the forefront of epigenetic research, offering researchers the means to dissect the molecular mechanisms underlying Mel-18 function and its impact on gene expression in diverse cellular contexts. The continual exploration of these activators will undoubtedly deepen our understanding of Mel-18-mediated epigenetic regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 is a histone methyltransferase G9a/GLP inhibitor that indirectly influences Mel-18 activity. By inhibiting G9a/GLP, UNC1999 modulates histone methylation patterns, potentially impacting the function of Polycomb group proteins, including Mel-18. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 is a histone methyltransferase G9a inhibitor that indirectly influences Mel-18 activity. By targeting G9a, UNC0638 modulates histone methylation patterns, potentially affecting the function of Polycomb group proteins, including Mel-18. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A-366 is a histone methyltransferase G9a inhibitor that indirectly influences Mel-18 activity. By inhibiting G9a, A-366 modulates histone methylation patterns, potentially impacting the function of Polycomb group proteins, including Mel-18. | ||||||
UNC 0642 | 1481677-78-4 | sc-397059 | 10 mg | $230.00 | 3 | |
UNC0642 is a histone methyltransferase G9a inhibitor that indirectly influences Mel-18 activity. By targeting G9a, UNC0642 modulates histone methylation patterns, potentially affecting the function of Polycomb group proteins, including Mel-18. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $120.00 | 5 | |
Chaetocin is a histone methyltransferase SUV39H1 inhibitor that indirectly influences Mel-18 activity. By inhibiting SUV39H1, Chaetocin modulates histone methylation patterns, potentially impacting the function of Polycomb group proteins, including Mel-18. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $148.00 $452.00 | 1 | |
GSK343 is a histone methyltransferase EZH2 inhibitor that indirectly influences Mel-18 activity. By targeting EZH2, GSK343 modulates histone methylation patterns, potentially affecting the function of Polycomb group proteins, including Mel-18. | ||||||